sb 203580 has been researched along with hydrazinocurcumin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (hydrazinocurcumin) | Trials (hydrazinocurcumin) | Recent Studies (post-2010) (hydrazinocurcumin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 29 | 0 | 18 |
| Protein | Taxonomy | sb 203580 (IC50) | hydrazinocurcumin (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 6.292 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 0.1618 | |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | 7.3 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 9.7 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 9.7 | |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | 3.645 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, H; Jia, Y; Peng, L; Qiao, K; Wang, C; Xu, Z; Yang, W; Zhang, C; Zhang, Z | 1 |
1 other study(ies) available for sb 203580 and hydrazinocurcumin
| Article | Year |
|---|---|
Hydrazinocurcumin Induces Apoptosis of Hepatocellular Carcinoma Cells Through the p38 MAPK Pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Curcumin; Hep G2 Cells; Humans; Hydrazines; Imidazoles; Liver Neoplasms; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Toxicity Tests, Subacute; Xenograft Model Antitumor Assays | 2021 |